Newborn screening analyzes biomarkers in DBS to detect metabolic disorders.
C26:0-LPC is a biomarker for X-ALD and other peroxisomal biogenesis disorders.
A method was developed that added C26:0-LPC to dried blood spot analysis.
The method uses a single punch, extraction, and analysis by FIA–ESI–MS/MS.
C26:0-LPC, amino acids, acylcarnitines, and SUAC are simultaneously quantitated.